"The Multiple Sclerosis Center of Atlanta (MSCA) is a registered 501(C)(3) non-profit, providing comprehensive health care services for people living with Multiple Sclerosis, Parkinson's Disease, Epilepsy, Alzheimer's, Dementia, and other neurological conditions, Founded in 2001 by William H. Stuart, MD, MSCA provides patients and their families with access to the latest in research, education, and treatment options."

During the past decade, Ms Center Of Atlanta conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ms Center Of Atlanta" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 4 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ms Center Of Atlanta" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ms Center Of Atlanta" are "Multiple Sclerosis" (7 trials), "Alzheimer's Disease" (4 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Multiple Sclerosis (MS)" (2 trials) and "Relapsing Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Ms Center Of Atlanta" in a lesser frequency.

Most popular intervention types in "Ms Center Of Atlanta" are "Drug" (17 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ocrelizumab" (3 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Lanabecestat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ms Center Of Atlanta" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Ms Center Of Atlanta". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Ms Center Of Atlanta, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ms Center Of Atlanta, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".